Houston Methodist ramps up plasma therapy as FDA approves clinical trial

(Houston Methodist) The FDA's announcement Friday to approve convalescent serum therapy as a large-scale clinical trial opened the door for more patients to receive the potentially life-saving gift of a donor's plasma.